Loading…
Pulmonx Corporation is projected to rise to $1.93 by 2027, a +25% move from its current price of $1.54. LUNG is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.48 | $1.54 | $1.60 | -0.02% |
| May 30 | $1.46 | $1.54 | $1.62 | -0.04% |
| May 31 | $1.44 | $1.54 | $1.64 | -0.05% |
| Jun 1 | $1.43 | $1.54 | $1.66 | -0.07% |
| Jun 2 | $1.42 | $1.54 | $1.67 | -0.09% |
| Jun 3 | $1.41 | $1.54 | $1.68 | -0.11% |
| Jun 4 | $1.40 | $1.54 | $1.70 | -0.13% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.40 | $1.54 | $1.70 | -0.13% |
| Week 2 | $1.34 | $1.54 | $1.76 | -0.25% |
| Week 3 | $1.30 | $1.53 | $1.82 | -0.37% |
| Week 4 | $1.26 | $1.53 | $1.86 | -0.50% |
| Week 5 | $1.23 | $1.53 | $1.90 | -0.62% |
| Week 6 | $1.20 | $1.53 | $1.94 | -0.75% |
| Week 7 | $1.18 | $1.53 | $1.98 | -0.87% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves.
It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
The stock is currently priced at $1.55. It is a small-cap asset with a market capitalization of $65.47M and a rank of 4467. The long-term outlook is bullish, with the average price forecast rising in later years; for example, the 2030 average is $1.94 and the 2050 average is $6.26, with ROI figures reaching as high as 303.9 by 2050.
These projections are estimates and not guarantees.
A major floor 30.7% below — a decisive break under it would weaken the trend.
The nearest floor, 22.1% below — buyers have tended to step in here.
Price is pressing into resistance (1.9% away) — a breakout level to watch.
A major ceiling 31.2% above — clearing it would confirm fresh momentum.
Key LUNG support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LUNG market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.55 | Sell | $1.52 | Buy |
| MA 10 | $1.43 | Buy | $1.46 | Buy |
| MA 20 | $1.36 | Buy | $1.41 | Buy |
| MA 50 | $1.35 | Buy | $1.41 | Buy |
| MA 100 | $1.54 | Buy | $1.54 | Sell |
| MA 200 | $1.67 | Sell | $2.04 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.64 | Neutral |
| Stoch RSI (14) | 85.42 | Sell |
| CCI (20) | 127.70 | Buy |
| Williams %R (14) | -9.68 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 22.22 | Buy |
| Bollinger %B (20,2) | 0.90 | Neutral |
| Stochastic %K (14) | 90.32 | Sell |
| TRIX (15) | 0.14 | Buy |
| Awesome (5,34) | 0.19 | Buy |
| Ultimate (7,14,28) | 80.64 | Sell |
| Momentum (10) | 0.25 | Buy |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 1.62 | Sell |
| ADX (14) | 16.43 | Neutral |
| ATR (14) | 0.04 | Info |
The 30-day technical picture is bullish, with RSI(14) at 70. The 50-day simple moving average is $1.35, and the 200-day simple moving average is $1.67. Nearby support sits at $1.20 and resistance at $1.55. The 30-day price range runs from $1.20 to $2.00, and annualized volatility is 70%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.17 | $1.54 | $2.17 | 0% | Neutral | |
| $1.48 | $1.93 | $2.70 | +25% | Bullish | |
| $1.41 | $1.91 | $2.79 | +24% | Bullish | |
| $1.44 | $2.01 | $3.05 | +31% | Bullish | |
| $1.34 | $1.94 | $3.03 | +26% | Bullish | |
| $1.29 | $1.90 | $3.05 | +24% | Bullish | |
| $1.38 | $2.09 | $3.43 | +36% | Bullish | |
| $1.46 | $2.27 | $3.81 | +48% | Bullish | |
| $1.79 | $2.85 | $4.87 | +85% | Bullish | |
| $1.88 | $3.06 | $5.33 | +99% | Bullish | |
| $2.09 | $3.75 | $7.03 | +143% | Bullish | |
| $2.99 | $6.45 | $13.49 | +319% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.17 | $1.54 | $1.81 | +0.00% |
| June 2026 | $1.25 | $1.48 | $1.80 | -3.75% |
| July 2026 | $1.27 | $1.52 | $1.88 | +2.22% |
| August 2026 | $1.30 | $1.57 | $1.97 | +3.42% |
| September 2026 | $1.26 | $1.53 | $1.95 | -2.09% |
| October 2026 | $1.25 | $1.53 | $1.97 | -0.00% |
| November 2026 | $1.32 | $1.63 | $2.10 | +6.00% |
| December 2026 | $1.34 | $1.66 | $2.17 | +2.30% |
Click any year to see its month-by-month LUNG forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, LUNG could reach as high as $2.17, with a base case around $1.54 and support toward $1.17 — roughly 0% from $1.54. A consolidation phase looks the most probable path here.
Expect LUNG to range from $1.48 to $2.70 through 2027. The $1.93 average target implies a +25% move from current prices. That is up +25% on the projected 2026 average. Momentum favours further upside here.
The LUNG price prediction for 2028 points to an average of $1.91 (low $1.41, high $2.79) — a potential gain of +24% on today's $1.54. Buyers look set to stay in control over this stretch.
In 2029, LUNG is projected to trade between $1.44 and $3.05, averaging $2.01 — a potential gain of +31% from today's $1.54. That is up +6% on the projected 2028 average. Momentum favours further upside here.
Pulmonx Corporation's 2030 outlook centres on $1.94, within a $1.34 to $3.03 range. That is -4% versus the projected 2029 average. That marks a +26% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, LUNG could reach as high as $3.05, with a base case around $1.90 and support toward $1.29 — roughly +24% from $1.54. Momentum favours further upside here.
Expect LUNG to range from $1.38 to $3.43 through 2032. The $2.09 average target implies a +36% move from current prices. That is up +10% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The LUNG price prediction for 2033 points to an average of $2.27 (low $1.46, high $3.81) — a potential gain of +48% on today's $1.54. Momentum favours further upside here.
In 2034, LUNG is projected to trade between $1.79 and $4.87, averaging $2.85 — a potential gain of +85% from today's $1.54. That is up +25% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Pulmonx Corporation's 2035 outlook centres on $3.06, within a $1.88 to $5.33 range. That is up +7% on the projected 2034 average. That marks a +99% change versus current levels. Momentum favours further upside here.
By 2040, LUNG could reach as high as $7.03, with a base case around $3.75 and support toward $2.09 — roughly +143% from $1.54. Buyers look set to stay in control over this stretch.
Expect LUNG to range from $2.99 to $13.49 through 2050. The $6.45 average target implies a +319% move from current prices. That is up +72% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in LUNG today (≈ 649.350649 LUNG) could be worth
$4,190.14
+$3,190.14 (+319%) by 2050 · US Dollar
Based on the average projected LUNG price of $6.45 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LUNGwould be worth at today's price.
$1,000 invested in LUNG on May 27, 2025 (≈ 324.149105 LUNG) would be worth
$499.19
-$500.81 (-50.1%) today · 0.50× · US Dollar
Based on a LUNG entry price of $3.09 vs. today's $1.54.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.54 | $1,000 | +0.0% |
| 1 month ago | $1.28 | $1,203.13 | +20.3% |
| 3 months ago | $1.64 | $939.02 | -6.1% |
| 6 months ago | $1.62 | $950.62 | -4.9% |
| 1 year ago | $3.09 | $499.19 | -50.1% |
| All time (5.0y) ago | $43.4 | $35.48 | -96.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LUNG forecast.
Our base-case forecast reaches $3.10 around 2040.
Implied market cap at $3.10: $130.94M
The multi-year forecast shows a bullish stance across the horizon. In 2026 the min is $1.17, the avg is $1.55, and the max is $2.19 (sentiment NEUTRAL). In 2027 the avg rises to $1.95 with a max of $2.75 and ROI of 25.7 (sentiment BULLISH).
In 2028 the avg is $1.93, max $2.85, ROI 24.4 (sentiment BULLISH). In 2029 the avg is $2.01, max $3.09, ROI 29.6 (sentiment BULLISH). In 2030 the avg is $1.94, min $1.32, max $3.07, ROI 24.9 (sentiment BULLISH).
In 2031 the avg is $1.89, max $3.08, ROI 22 (sentiment BULLISH). In 2032 the avg is $2.04, max $3.40, ROI 31.5 (sentiment BULLISH). In 2033 the avg is $2.24, max $3.83, ROI 44.7 (sentiment BULLISH).
In 2034 the avg is $2.84, max $4.95, ROI 83.3 (sentiment BULLISH). In 2035 the avg is $3.02, max $5.36, ROI 94.9 (sentiment BULLISH). In 2040 the avg is $3.68, max $7.06, ROI 137.6 (sentiment BULLISH).
In 2050 the avg is $6.26, max $13.41, ROI 303.9 (sentiment BULLISH). These are estimates and may change.
Tap a question to reveal the answer.
2026 min $1.17, avg $1.55, max $2.19; ROI 0; sentiment NEUTRAL.
Forecasts show bullish sentiment from 2027 onward, with 2027 avg $1.95, max $2.75 and ROI 25.7.
2035 max $5.36, avg $3.02, ROI 94.9.
2040 min $1.98, avg $3.68, max $7.06; ROI 137.6; sentiment BULLISH.
2050 min $2.82, avg $6.26, max $13.41; ROI 303.9; sentiment BULLISH.
Pulmonx Corporation Community Discussion
0Share your Pulmonx Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.